Clinical Trial Update: Impact of Surfactant's Availability on Newborns

View source ↗

Summary

A completed clinical trial assessing how the availability of surfactant therapy impacts outcomes for newborns with respiratory distress syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Surfactant therapy (surfactant)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Diseases, Respiratory Distress Syndrome | Status: COMPLETED